Role of the multidrug resistance protein-1 (MRP1) for endothelial progenitor cell function and survival

Journal of Molecular and Cellular Cardiology

Volumn 49, Issue 3, 2010, Pages 482-489

  Mueller, Cornelius F H ^a   Afzal, Shazia ^a   Becher, Ulrich Marc ^a   Wassmann, Sven ^a   Nickenig, Georg ^a   Wassmann, Kerstin ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Endothelial progenitor cells; Glutathione; Intracellular redox homeostasis; Multidrug resistance protein 1 (MRP1); Reendothelialization

Indexed keywords

GLUTATHIONE; MULTIDRUG RESISTANCE PROTEIN 1; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CAROTID ARTERY INJURY; CELL CULTURE; CELL FUNCTION; CELL PROTECTION; CELL SURVIVAL; COLONY FORMING UNIT; CONTROLLED STUDY; ENDOTHELIUM CELL; IN VITRO STUDY; IN VIVO STUDY; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL; WILD TYPE;

MUS;

EID: 77955266216     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.02.023     Document Type: Article

References (35)

1. Walter D.H., Rittig K., Bahlmann F.H., Kirchmair R., Silver M., Murayama T., et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002, 105:3017-3024.
2. Werner N., Wassmann S., Ahlers P., Schiegl T., Kosiol S., Link A., et al. Endothelial progenitor cells correlate with endothelial function in patients with coronary artery disease. Basic Res Cardiol 2007, 102:565-571.
3. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
4. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
5. Dernbach E., Urbich C., Brandes R.P., Hofmann W.K., Zeiher A.M., Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104:3591-3597.
6. Ingram D.A., Krier T.R., Mead L.E., McGuire C., Prater D.N., Bhavsar J., et al. Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 2007, 25:297-304.
7. Urbich C., Knau A., Fichtlscherer S., Walter D.H., Bruhl T., Potente M., et al. FOXO-dependent expression of the proapoptotic protein Bim: pivotal role for apoptosis signaling in endothelial progenitor cells. FASEB J 2005, 19:974-976.
8. Cole S.P., Bhardwaj G., Gerlach J.H., Mackie J.E., Grant C.E., Almquist K.C., et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 1992, 258:1650-1654.
9. Cole S.P., Deeley R.G. Transport of glutathione and glutathione conjugates by MRP1. Trends Pharmacol Sci 2006, 27:438-446.
10. Keppler D., Leier I., Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997, 378:787-791.
11. Keppler D. Export pumps for glutathione S-conjugates. Free Radic Biol Med 1999, 27:985-991.
12. Mueller C.F., Wassmann K., Widder J.D., Wassmann S., Chen C.H., Keuler B., et al. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation 2008, 117:2912-2918.
13. Mueller C.F., Widder J.D., McNally J.S., McCann L., Jones D.P., Harrison D.G. The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 2005, 97:637-644.
14. Hirschi K.K., Ingram D.A., Yoder M.C. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 2008, 28:1584-1595.
15. Wassmann S., Werner N., Czech T., Nickenig G. Improvement of endothelial function by systemic transfusion of vascular progenitor cells. Circ Res 2006, 99:e74-e83.
16. Fontaine V., Filipe C., Werner N., Gourdy P., Billon A., Garmy-Susini B., et al. Essential role of bone marrow fibroblast growth factor-2 in the effect of estradiol on reendothelialization and endothelial progenitor cell mobilization. Am J Pathol 2006, 169:1855-1862.
17. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
18. Duda D.G., Cohen K.S., Scadden D.T., Jain R.K. A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2007, 2:805-810.
19. Strehlow K., Werner N., Berweiler J., Link A., Dirnagl U., Priller J., et al. Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003, 107:3059-3065.
20. Urbich C., Dimmeler S. Risk factors for coronary artery disease, circulating endothelial progenitor cells, and the role of HMG-CoA reductase inhibitors. Kidney Int 2005, 67:1672-1676.
21. Vasa M., Fichtlscherer S., Aicher A., Adler K., Urbich C., Martin H., et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001, 89:E1-E7.
22. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005, 353:999-1007.
23. Dernbach E., Urbich C., Brandes R.P., Hofmann W.K., Zeiher A.M., Dimmeler S. Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress. Blood 2004, 104:3591-3597.
24. Case J., Ingram D.A., Haneline L.S. Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal 2008, 10:1895-1907.
25. Case J., Ingram D.A., Haneline L.S. Oxidative stress impairs endothelial progenitor cell function. Antioxid Redox Signal 2008, 10:1895-1907.
26. Ingram D.A., Krier T.R., Mead L.E., McGuire C., Prater D.N., Bhavsar J., et al. Clonogenic endothelial progenitor cells are sensitive to oxidative stress. Stem Cells 2007, 25:297-304.
27. Mueller C.F., Wassmann K., Widder J.D., Wassmann S., Chen C.H., Keuler B., et al. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation 2008, 117:2912-2918.
28. Mueller C.F., Widder J.D., McNally J.S., McCann L., Jones D.P., Harrison D.G. The role of the multidrug resistance protein-1 in modulation of endothelial cell oxidative stress. Circ Res 2005, 97:637-644.
29. Mueller C.F., Wassmann K., Widder J.D., Wassmann S., Chen C.H., Keuler B., et al. Multidrug resistance protein-1 affects oxidative stress, endothelial dysfunction, and atherogenesis via leukotriene C4 export. Circulation 2008, 117:2912-2918.
30. Akerboom T.P., Sies H. Transport of glutathione disulfide and glutathione S-conjugates in hepatocyte plasma membrane vesicles. Methods Enzymol 1994, 233:416-425.
31. Keppler D., Leier I., Jedlitschky G. Transport of glutathione conjugates and glucuronides by the multidrug resistance proteins MRP1 and MRP2. Biol Chem 1997, 378:787-791.
32. Keppler D. Export pumps for glutathione S-conjugates. Free Radic Biol Med 1999, 27:985-991.
33. Hirrlinger J., Konig J., Dringen R. Expression of mRNAs of multidrug resistance proteins (Mrps) in cultured rat astrocytes, oligodendrocytes, microglial cells and neurones. J Neurochem 2002, 82:716-719.
34. Knollema S., Hom H.W., Schirmer H., Korf J., Ter Horst G.J. Immunolocalization of glutathione reductase in the murine brain. J Comp Neurol 1996, 373:157-172.
35. Balcerczyk A., Rychlik B., Kruszewski M., Burchell B., Bartosz G. MRP1-transfected cells do not show increased resistance against oxidative stress. Free Radic Res 2003, 37:189-195.